PEOPLE - UroCor in the US makes appointment:
This article was originally published in Clinica
UroCor in the US has appointed Michael George, previously with DuPont Merck Pharmaceuticals, to the new position of chief operating officer. He will also take over as president from William Hagstrom, who remains as CEO and chairman. UroCor markets products for the diagnosis and treatment of urological disorders.